https://novaprd-lb.newcastle.edu.au/vital/access/manager/Index en-au 5 The relationship between white matter microstructure and general cognitive ability in patients with schizophrenia and healthy participants in the ENIGMA consortium https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:40457 Wed 27 Jul 2022 11:14:03 AEST ]]> Differential effect of disease-associated ST8SIA2 haplotype on cerebral white matter diffusion properties in schizophrenia and healthy controls https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:34987 Wed 24 Nov 2021 15:52:45 AEDT ]]> Paracingulate sulcus morphology is associated with hallucinations in the human brain https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:22665 Wed 11 Apr 2018 12:37:33 AEST ]]> Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:40024 Thu 21 Jul 2022 09:47:00 AEST ]]> Australian schizophrenia research bank: a database of comprehensive clinical, endophenotypic and genetic data for aetiological studies of schizophrenia https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:10415 Sat 24 Mar 2018 08:12:38 AEDT ]]> Biological insights from 108 schizophrenia-associated genetic loci https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:21465 DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that have important roles in immunity, providing support for the speculated link between the immune system and schizophrenia.]]> Sat 24 Mar 2018 07:52:31 AEDT ]]> White matter disruptions in schizophrenia are spatially widespread and topologically converge on brain network hubs https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:30942 Sat 24 Mar 2018 07:33:42 AEDT ]]> The effect of a muscarinic receptor 1 gene variant on grey matter volume in schizophrenia https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:22690 A single nucleotide polymorphism (rs2067477) within the cholinergic muscarinic M1 receptor (CHRM1) perform less well on the Wisconsin Card Sorting Test (WCST) than those who are heterozygous. This study sought to determine whether variation in the rs2067477 genotype was associated with differential changes in brain structure. Data from 227 patients with established schizophrenia or schizoaffective disorder were obtained from the Australian Schizophrenia Research Bank. Whole-brain voxel-based morphometry was performed to compare regional grey matter volume (GMV) between the 267C/C (N=191) and 267C/A (N=36) groups. Secondary analyses tested for an effect of genotype on cognition (the WCST was not available). Individuals who were homozygous (267C/C) demonstrated significantly reduced GMV in the right precentral gyrus compared to those who were heterozygous (267C/A). These preliminary results suggest that the rs2067477 genotype is associated with brain structure in the right precentral gyrus in individuals with schizophrenia/schizoaffective disorder. Future studies are required to replicate these results and directly link the volumetric reductions with specific cognitive processes.]]> Sat 24 Mar 2018 07:11:11 AEDT ]]> Wnt receptor gene FZD1 was associated with schizophrenia in genome-wide SNP analysis of the Australian Schizophrenia Research Bank cohort https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:44131 Sat 08 Oct 2022 12:36:32 AEDT ]]> Large-Scale Evidence for an Association between Peripheral Inflammation and White Matter Free Water in Schizophrenia and Healthy Individuals https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:46105 Fri 11 Nov 2022 11:44:05 AEDT ]]>